Strain-specific requirement for eosinophils in the recruitment of T cells to the lung during the development of allergic asthma

Journal of Experimental Medicine

Volumn 205, Issue 6, 2008, Pages 1285-1292

  Walsh, Elizabeth Rose ^a   Sahu, Nisebita ^a   Kearley, Jennifer ^b   Benjamin, Ebony ^b   Boo, Hyon Kang ^c   Humbles, Alison ^b   August, Avery ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

^b MEDIMMUNE   (United States)

^c Medvill Co   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; EOTAXIN; EOTAXIN 2; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; MONOCYTE CHEMOTACTIC PROTEIN 3; OVALBUMIN;

ALLERGIC ASTHMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BAGG ALBINO MOUSE; BRONCHUS HYPERREACTIVITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; EOSINOPHIL; GENE MUTATION; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TRANSGENIC MOUSE;

ANIMALS; ASTHMA; BRONCHIAL HYPERREACTIVITY; EOSINOPHILS; GATA1 TRANSCRIPTION FACTOR; HYPERSENSITIVITY; INFLAMMATION; INTERLEUKINS; LUNG; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; OVALBUMIN; SPECIES SPECIFICITY; T-LYMPHOCYTES;

EID: 45149085743     PISSN: 00221007     EISSN: 00221007     Source Type: Journal    
DOI: 10.1084/jem.20071836     Document Type: Article

References (31)

1. Wills-Karp, M., and C. Karp. 2004. Eosinophils in asthma: remodeling a tangled tale. Science. 305:1726-1729.
2. Bousquet, J., P. Chanez, J. Lacoste, G. Barneon, N. Ghavanian, I. Enander, P. Venge, S. Ahlstedt, J. Simony-Lafontaine, P. Godard, et al. 1990. Eosinophilic inflammation in asthma. N. Engl. J. Med. 323:1033-1039.
3. Kay, A.B., S. Phipps, and D. Robinson. 2004. A role for eosinophils in airway remodelling in asthma. Trends Immunol. 25:477-482.
4. Rothenberg, M.E., and S. Hogan. 2006. The eosinophil. Annu. Rev. Immunol. 24:147-174.
5. Hamelmann, E., G. Cieslewicz, J. Schwarze, T. Ishizuka, A. Joetham, C. Heusser, and E. Gelfand. 1999. Anti-interleukin 5 but not anti-IgE prevents airway inflammation and airway hyperresponsiveness. Am. J. Respir. Crit. Care Med. 160:934-941.
6. Leckie, M.J., A. ten Brinke, J. Khan, Z. Diamant, B. O'Connor, C. Walls, A. Mathur, H. Cowley, K. Chung, R. Djukanovic, et al. 2000. Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyperresponsiveness, and the late asthmatic response. Lancet. 356:2144-2148.
7. Kumar, R., C. Herbert, D. Webb, L. Li, and P. Foster. 2004. Effects of anticytokine therapy in a mouse model of chronic asthma. Am. J. Respir. Crit. Care Med. 170:1043-1048.
8. Mathur, M., K. Herrmann, X. Li, Y. Qin, J. Weinstock, D. Elliott, J. Monahan, and P. Padrid. 1999. TRFK-5 reverses established airway eosinophilia but not established hyperresponsiveness in a murine model of chronic asthma. Am. J. Respir. Crit. Care Med. 159:580-587.
9. Bochner, B.S. 2004. Verdict in the case of therapies versus eosinophils: the jury is still out. J. Allergy Clin. Immunol. 113:3-9.
10. Sugita, M., K. Kuribayashi, T. Nakagomi, S. Miyata, T. Matsuyama, and O. Kitada. 2003. Allergic bronchial asthma: airway inflammation and hyperresponsiveness. Intern. Med. 42:636-643.
11. Cohn, L.C., J. Elias, and G. Chupp. 2004. Asthma: mechanisms of disease persistence and progression. Annu. Rev. Immunol. 22:789-815.
12. Borish, L., H. Nelson, M. Lanz, L. Claussen, J. Whitmore, J. Agosti, and L. Garrison. 1999. Interleukin-4 receptor in moderate atopic asthma. A phase I/II randomized, placebo-controlled trial. Am. J. Respir. Crit. Care Med. 160:1816-1823.
13. Wills-Karp, M., J. Luyimbazi, X. Xu, B. Schofield, T. Neben, C. Karp, and D. Donaldson. 1998. Interleukin-13: central mediator of allergic asthma. Science. 282:2258-2261.
14. Grunig, G., M. Warnock., A.E. Wakil, R. Venkayya, F. Brombacher, D.M. Rennick, D. Sheppard, M. Mohrs, D.D. Donaldson, R.M. Locksley, and D.B. Corry. 1998. Requirement for IL-13 independently of IL-4 in experimental asthma. Science. 282:2261-2263.
15. Pope, S.M., E. Brandt, A. Mishra, S. Hogan, N. Zimmermann, K. Matthaei, P. Foster, and M. Rothenberg. 2001. IL-13 induces eosinophil recruitment into the lung by an IL-5- and eotaxin-dependent mechanism. J. Allergy Clin. Immunol. 108:594-601.
16. Li, L., Y. Xia, A. Nguyen, Y. Lai, L. Feng, T. Mosmann, and D. Lo. 1999. Effects of Th2 cytokines on chemokine expression in the lung: IL-13 potently induces eotaxin expression by airway epithelial cells. J. Immunol. 162:2477-2487.
17. Mattes, J., M. Yang, S. Mahalingam, J. Kuehr, D. Webb, L. Simson, S. Hogan, A. Koskinen, A. McKenzie, L. Dent, et al. 2002. Intrinsic defect in T cell production of interleukin (IL)-13 in the absence of both IL-5 and eotaxin precludes the development of eosinophilia and airways hyperreactivity in experimental asthma. J. Exp. Med. 195:1433-1444.
18. Lee, J.J., D. Dimina, M. Macias, S. Ochkur, M. McGarry, K. O ' Neill, C. Protheroe, R. Pero, T. Nguyen, S. Cormier, et al. 2004. Defining a link with asthma in mice congenitally deficient in eosinophils. Science. 305:1773-1776.
19. Humbles, A.A., C. Lloyd, S. McMillan, D. Friend, G. Xanthou, E. McKenna, S. Ghiran, N. Gerard, C. Yu, S. Orkin, and C. Gerard. 2004. A critical role for eosinophils in allergic airways remodeling. Science. 305:1776-1779.
20. Hogan, S.P., K. Matthaei, J. Young, A. Koskinen, I. Young, and P. Foster. 1998. A novel T cell-regulated mechanism modulating allergen-induced airways hyperreactivity in BALB/c mice independently of IL-4 and IL-5. J. Immunol. 161:1501-1509.
21. Webb, D.C., A. McKenzie, A. Koskinen, M. Yang, J. Mattes, and P. Foster. 2000. Integrated signals between IL-13, IL-4, and IL-5 regulate airways hyperreactivity. J. Immunol. 165:108-113.
22. Tamura, N., N. Ishii, M. Nakazawa, M. Nagoya, M. Yoshinari, T. Amano, H. Nakazima, and M. Minami. 1996. Requirement of CD80 and CD86 molecules for antigen presentation by eosinophils. Scand. J. Immunol. 44:229-238.
23. Padigel, U.M., J. Lee, T. Nolan, G. Schad, and D. Abraham. 2006. Eosinophils can function as antigen-presenting cells to induce primary and secondary immune responses to Strongyloides stercoralis. Infect. Immun. 74:3232-3238.
24. Pope, S.M., P. Fulkerson, C. Blanchard, H. Akei, N. Nikolaidis, N. Zimmermann, J. Molkentin, and M. Rothenberg. 2005. Identification of a cooperative mechanism involving interleukin-13 and eotaxin-2 in experimental allergic lung inflammation. J. Biol. Chem. 280:13952-13961.
25. Lloyd, C.M., T. Delaney, T. Nguyen, J. Tian, C. Martinez-A, A.J. Coyle, and J.-C. Gutierrez-Ramos. 2000. CC chemokine receptor (CCR)3/eotaxin is followed by CCR4/monocyte-derived chemokine in mediating pulmonary T helper lymphocyte type 2 recruitment after serial antigen challenge in vivo. J. Exp. Med. 191:265-274.
26. Yang, M., S. Hogan, S. Mahalingam, S. Pope, N. Zimmermann, P. Fulkerson, L. Dent, I. Young, K. Matthaei, M. Rothenberg, and P. Foster. 2003. Eotaxin-2 and IL-5 cooperate in the lung to regulate IL-13 production and airway eosinophilia and hyperreactivity. J. Allergy Clin. Immunol. 112:935-943.
27. Voehringer, D., T. Reese, X. Huang, K. Shinkai, and R. Locksley. 2006. Type 2 immunity is controlled by IL-4/IL-13 expression in hematopoietic non-eosinophil cells of the innate immune system. J. Exp. Med. 203:1435-1446.
28. Fulkerson, P.C., C. Fischetti, M. McBride, L. Hassman, S. Hogan, and M. Rothenberg. 2006. A central regulatory role for eosinophils and the eotaxin/CCR3 axis in chronic experimental allergic airway inflammation. Proc. Natl. Acad. Sci. USA. 103:16418-16423.
29. Jacobsen, E., S. Ochkur, R. Pero, A. Taranova, C. Protheroe, D. Colbert, N. Lee, and J. Lee. 2008. Allergic pulmonary inflammation in mice is dependent on eosinophil-induced recruitment of effector T cells. J. Exp. Med. 205:699-710.
30. Lee, N.A., M. McGarry, K. Larson, M. Horton, A. Kristensen, and J. Lee. 1997. Expression of IL-5 in thymocytes/T cells leads to the development of a massive eosinophilia, extramedullary eosinophilopoiesis, and unique histopathologies. J. Immunol. 158:1332-1344.
31. Ewart, S., R. Levitt, and W. Mitzner. 1995. Respiratory system mechanics in mice measured by end-inflation occlusion. J. Appl. Physiol. 79:560-566.